BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33219856)

  • 1. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
    Rolf D; Elsayad K; Eich HT
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
    Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
    Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
    Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
    J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
    J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
    Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
    Elsayad K; Susek KH; Eich HT
    Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
    Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
    J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
    Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
    Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.
    Elsayad K; Rolf D; Sunderkötter C; Weishaupt C; Müller EC; Nawar T; Stranzenbach R; Livingstone E; Stadler R; Steinbrink K; Moritz RKC; Eich HT
    J Dtsch Dermatol Ges; 2022 Mar; 20(3):279-285. PubMed ID: 34984837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
    Chowdhary M; Chhabra AM; Kharod S; Marwaha G
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
    Durgin JS; Jariwala NN; Wysocka M; Zhang KK; Maity A; Benoit B; Plastaras JP; Lewis DJ; Rosenthal JM; Teague JE; Berg S; Del Guzzo C; Kim EJ; Vittorio C; Haun PL; Samimi SS; Villasenor-Park J; Inverso J; Clark RA; Rook AH
    JAMA Dermatol; 2021 Jan; 157(1):90-95. PubMed ID: 33112366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
    Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
    Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?
    Chowdhary M; Song A; Zaorsky NG; Shi W
    Chin Clin Oncol; 2019 Feb; 8(1):9. PubMed ID: 30525748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.